Synergistic antitumor activity of histone deacetylase inhibitors and anti-ErbB3 antibody in NSCLC primary cultures via modulation of ErbB receptors expression

Chiara Ciardiello(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Alessandra Leone(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale")
Oncotarget
February 4, 2016
Cited by 24


Related Papers